Posts Tagged ‘topical’
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
FDA Issues Warning Letters To Marketers Of Topical Ibuprofen Drug Products
The U.S. Food and Drug Administration announced that the agency issued warning letters to eight companies marketing unlawful over-the-counter (OTC) topical drug products containing the pain reliever ibuprofen. The products, which contain ibuprofen in combination with a variety of other active ingredients and are marketed for pain relief, are unapproved new drugs that require an approved new drug application in order to be legally marketed.
Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities To Evaluate Effectiveness Of Stopain Topical Analgesic
DRJ Group Inc., the makers of all-natural Stopain(R) topical analgesics, announced the results of an informal study conducted with chronic pain sufferers at two adult foster care facilities. The test was conducted with residents living at two facilities owned by Leon and Paulette Hanson in Cannon Falls, Minn. The Hansons approached the DRJ Group about conducting an informal study after receiving a complimentary sample of Stopain.
Fast Acting, Long Lasting Topical Relief From Arthritis Pain
Every day, 70 million Americans suffer from the aches and pains that come with arthritis and other chronic joint problems(1). One of the most effective ways to get fast relief from arthritis pain is the use of analgesic creams. The only problem is that the relief tends to be short-lived. Many people find that within 45 minutes to an hour and a half after applying a cream, the pain comes right back. RZN Nutraceuticals,
Cerimon Pharmaceuticals Initiates Phase III Clinical Studies To Evaluate Its Topical Diclofenac Sodium Patch For Mild-to-Moderate Pain
Cerimon Pharmaceuticals, Inc., announced the Company has enrolled its first subjects in its once-daily topical diclofenac sodium patch Phase III program. The program consists of three randomized, double-blind, placebo-controlled Phase III clinical studies with Cerimon’s diclofenac patch.
Rx Drug Compare
Translator
By N2H